Semaglutide 20mg

Semaglutide 20 mg is a high-purity synthetic analog of glucagon-like peptide-1 (GLP-1), designed for advanced metabolic and endocrine research. This extended-dose formulation provides additional material for studies requiring larger-scale or long-term assays of peptide stability, GLP-1 receptor activity, and glucose-homeostasis modeling. Structural substitutions enhance resistance to enzymatic degradation, prolonging half-life and bioavailability under controlled experimental conditions.